Women experiencing intimate partner violence three times more likely to contract HIV
Women who experience recent intimate partner violence (IPV) are three times more likely to contract HIV, according to a new study led by McGill University researchers. In regions like Sub-Saharan Africa, women face an intersecting epidemic of intimate partner violence and HIV.
“Worldwide, more than one in four women experience intimate partner violence in their lifetime," says McGill University Professor Mathieu Maheu-Giroux, a Canada Research Chair in Population Health Modeling.
"Sub-Saharan Africa is among one of the regions in the world with the highest prevalence of both IPV and HIV. We wanted to examine the effects of intimate partner violence on recent HIV infections and women’s access to HIV care in this region,” he says.
Their study, published in The Lancet HIV, shows considerable overlap between violence against women and the HIV epidemics in some of the highest burdened countries. Among women living with HIV, those experiencing intimate partner violence were nine per cent less likely to achieve viral load suppression – the ultimate step in HIV treatment.
New calls to eliminate all forms of sexual and gender-based violence
“The 2021 UN General Assembly, attended and supported by the Government of Canada, adopted the Political Declaration on HIV and AIDS with bold new global targets for 2025. This encompasses a commitment to eliminate all forms of sexual and gender-based violence, including IPV, as a key enabler of the HIV epidemic. Improving our understanding of the relationships between IPV and HIV is essential to meet this commitment,” says Professor Maheu-Giroux.
The researchers found that physical or sexual intimate partner violence in the past year was associated with recent HIV acquisition and less frequent viral load suppression. According to the researchers, IPV could also pose barriers for women in accessing HIV care and remaining in care while living with the virus.
“Given the high burden of IPV worldwide, including in Canada, the need to stem the mutually reinforcing threats of IPV and HIV on women’s health and well-being is urgent," says Salome Kuchukhidze, a PhD candidate studying epidemiology and the lead author of the research.
About the study
“The effects of intimate partner violence on women’s risk of HIV acquisition and engagement in the HIV treatment and care cascade: a pooled analysis of nationally representative surveys in sub-Saharan Africa” by Salome Kuchukhidze, Dimitra Panagiotoglou, Marie-Claude Boily, Souleymane Diabaté, Jeffrey Eaton, Francisco Mbofana, Lynnmarie Sardinha, Leah Schrubbe, Heidi Stöckl, Rhoda Wanyenze, and Mathieu Maheu-Giroux was published in The Lancet HIV.
About McGill University
Founded in Montreal, Quebec, in 1821, McGill University is Canada’s top ranked medical doctoral university. McGill is consistently ranked as one of the top universities, both nationally and internationally. It is a world-renowned institution of higher learning with research activities spanning three campuses, 11 faculties, 13 professional schools, 300 programs of study and over 39,000 students, including more than 10,400 graduate students. McGill attracts students from over 150 countries around the world, its 12,000 international students making up 30% of the student body. Over half of McGill students claim a first language other than English, including approximately 20% of our students who say French is their mother tongue.